U.S. Office REITs Stock News

What Adeia’s Leadership Shake-Up Could Mean for Shareholders Adeia (ADEA) has just reshaped its senior ranks, bringing in new leaders for semiconductor R&D, revenue, and corporate planning while planning for a key executive exit. This is a shift investors will likely watch closely. See our latest analysis for Adeia. At a share price of $18.79, Adeia has seen a 47.37% 90 day share price return and a 50.74% 1 year total shareholder return, which indicates recent momentum ahead of these...

Cavco Industries (CVCO) opened its Q3 2026 update with revenue of US$581.0 million and basic EPS of US$5.65, alongside trailing twelve month figures of US$2.2 billion in revenue and EPS of US$23.28 that continue to frame the earnings story. The company has seen quarterly revenue move from US$508.4 million in Q4 2025 to the mid US$500 million range in the first half of 2026, while basic EPS has ranged between US$4.53 and US$6.97 over the past six reported quarters, giving investors a clear...

Why Opendoor Technologies is Back on Watchlists Opendoor Technologies (OPEN) has drawn fresh attention after recent share price moves, with the stock now around $4.82. That puts recent performance, business fundamentals, and risk profile in sharper focus for investors. See our latest analysis for Opendoor Technologies. While the latest 1-day share price return of a 6.41% decline to US$4.82 adds short-term pressure, the 1-year total shareholder return of 265.15% and 3-year total shareholder...

How the Inpefa launch ties into the Viatris (VTRS) story Viatris (VTRS) is in focus after launching Inpefa, or sotagliflozin, in the United Arab Emirates, its first commercialization of the heart failure treatment within its territories outside the U.S. and Europe. The move connects directly to the company’s effort to widen access to a dual SGLT1/2 inhibitor in cardiovascular care across additional markets, following its licensing agreement with Lexicon Pharmaceuticals and a series of...

In early February 2026, Medtronic reported three major U.S. milestones for its MiniMed 780G insulin delivery system, including Medicare access when paired with Abbott’s Instinct sensor, FDA clearance to use ultra rapid-acting insulins, and expanded clearance for insulin-requiring type 2 diabetes. By combining automated insulin delivery, longer-wear discreet sensing, and more flexible insulin options, Medtronic is aiming to make intensive diabetes management less burdensome and more tailored...

XPeng Inc. reported that it delivered 20,011 vehicles in January 2026 and launched its P7+ model globally, including a European debut at the Brussels Motor Show. The company linked these deliveries to a sizeable reduction in life-cycle greenhouse gas emissions and highlighted its push into advanced AI, in-house chip development, and next-generation mobility as it expands beyond its home market. We’ll now examine how XPeng’s global P7+ launch and technology push might influence the company’s...

Chewy (CHWY) is back in focus after reporting earnings that topped revenue and profit expectations, while also announcing the upcoming retirement of Chief Technology Officer Satish Mehta and the search for his successor. See our latest analysis for Chewy. Despite the latest earnings beat and leadership headlines, Chewy’s share price has been under pressure, with a 30 day share price return of a 15.23% decline and a 1 year total shareholder return of a 25.56% decline, pointing to fading...

In early January 2026, the Trump administration announced measures barring large institutional investors from purchasing additional single-family homes in the U.S., directly affecting Invitation Homes’ ability to expand its rental portfolio. This policy shift highlights growing federal scrutiny of institutional ownership in the housing market, raising new questions about business models built on large-scale single-family rentals. We will now examine how this government restriction on...

Recent commentary around the Security and Safety Services industry has put Resideo Technologies (REZI) in focus, as demand for its First Alert SC5 connected detectors and ElitePRO smart thermostats attracts fresh attention from investors. See our latest analysis for Resideo Technologies. The recent focus on connected detectors and smart thermostats comes after a mixed price pattern, with Resideo Technologies’ share price returning 3.33% over one day but recording a 14.55% decline over 90...

Prologis (NYSE:PLD) has announced a planned $25b expansion into the data center market. The company aims to serve AI related demand by building and operating data center facilities alongside its logistics real estate. This move represents a diversification of Prologis's business beyond its traditional warehouse and industrial portfolio. Prologis, trading at $129.68, is widely known for its global logistics real estate footprint. Its shares have returned 14.0% over the past year and 39.3%...

Whirlpool (NYSE:WHR) is showcasing several first-of-their-kind home appliance features at the 2026 Kitchen & Bath Industry Show (KBIS). New products include a refrigerator with built-in nugget ice, UV Clean laundry sanitation, and smart cooking capabilities in KitchenAid appliances. The announcements span Whirlpool, KitchenAid, JennAir, and Maytag, highlighting connected features across multiple brands. For you as an investor, this KBIS announcement puts a spotlight on how Whirlpool...

Event driven snapshot Mobileye Global (MBLY) is on investors’ radar after a recent stretch of weak share performance, with the stock around $8.97 and negative returns over the past week, month and past 3 months prompting closer scrutiny. See our latest analysis for Mobileye Global. The recent 7 day share price return of negative 11.63% and 30 day share price return of negative 20.12%, with the stock at $8.97, adds to a weaker trend, reflected in a 1 year total shareholder return of negative...

Roku is facing a potential class action lawsuit over alleged screen defects in certain Roku TVs and related warranty limitations, while also rolling out features like a new unified Subscriptions Tab and enhanced Winter Olympics viewing tools in partnership with NBCUniversal. The contrast between product reliability concerns and Roku’s push to deepen user engagement on its platform highlights a tension between legal risk and ecosystem expansion. We’ll examine how rising legal scrutiny around...

If you are wondering whether Abercrombie & Fitch at around US$101 a share still offers value, or if most of the easy gains are already behind it, this article is for you. The stock is up 4.5% over the last week, after an 18.0% decline over the past month and an 18.0% drop year to date, with a 12.2% decline over the last year and a very large gain over the past 5 years. Recent attention on Abercrombie & Fitch has focused on its share price pullback after a very strong multi year run,...

Hubbell (NYSE:HUBB) has launched its Aclara360 software platform to support grid automation and utility operations. The platform is designed to give utilities stronger analytics, clearer operational visibility, and closer integration with existing systems. Hubbell also reported results from large scale utility pilot programs, providing real world validation of Aclara360’s capabilities. For investors watching Hubbell at a share price of $495.59, this product launch sits alongside multi year...

Immunocore Holdings (NasdaqGS:IMCR) announced the departure of Executive Vice President of Research and Development, Dr. David Berman. The company is not recruiting a direct replacement for the role and is instead restructuring its R&D leadership. Dr. Mohammed Dar and Mark Moyer have been promoted to Executive Vice President positions with expanded responsibilities. The leadership changes are intended to streamline R&D oversight and redistribute decision making across the senior...

InterDigital signed a new patent license agreement with LG Electronics covering digital TVs and computer display monitors. The company also renewed a patent license with a well established Chinese smartphone vendor. For investors watching NasdaqGS:IDCC, these fresh licensing deals come with the stock at $329.38 and very strong multi year share price gains, including 82.8% over the past year and a very large 3 year return. The agreements highlight InterDigital's role as a key licensor of...

Arm Holdings recently reported its strongest-ever quarter, unveiled its Lumex CSS on-device AI platform, and announced major AI collaborations with Meta, Amazon Web Services, Google, and Apple, reinforcing its role at the core of data center and edge AI infrastructure. An especially important development is Arm’s unified AI computing push with Meta and long-term licensing deals extending with partners like Apple beyond 2040, which together suggest a deeper and more durable integration of Arm...

D-Wave Quantum (NYSE:QBTS) has relocated its headquarters to Florida and expanded its U.S. R&D operations. The company has deepened regional ties through a new collaboration with Florida Atlantic University. D-Wave introduced new hybrid solver capabilities and moved faster on gate-model quantum development. A recent defense technology collaboration highlighted material real-world use cases for its systems. D-Wave Quantum, listed on the NYSE under ticker QBTS, focuses on quantum computing...

Royal Caribbean Group reported past fourth-quarter 2025 revenue of US$4.26 billion and net income of US$754 million, alongside full-year revenue of US$17.94 billion and net income of US$4.27 billion, as it issued upbeat 2026 guidance and completed a US$200 million share buyback. The company also unveiled long-term growth plans, including ordering two new Discovery Class ocean ships with options for four more and expanding its Celebrity River Cruises fleet, underpinned by what management...

Gilead Sciences (NasdaqGS:GILD) has expanded its oncology pipeline through a new licensing deal with Repare Therapeutics. Phase 3 data for Trodelvy combined with Merck's Keytruda in first line metastatic triple negative breast cancer were published in The New England Journal of Medicine. These updates highlight oncology as an increasingly important area within Gilead's broader portfolio. For you as an investor, the story at Gilead is increasingly about oncology rather than only virology and...

United Therapeutics recently reported positive phase 1 results for miroliverELAP, an investigational external liver assist device tested in five acute liver failure patients who were not transplant candidates, with survival achieved during treatment and no unexpected serious adverse events over 32 days of follow-up. This early success underscores the company’s broader push into bioengineered organ alternatives, potentially expanding its role beyond pulmonary disease into life-support...

Vishay Intertechnology (VSH) has rolled out a series of new silicon carbide MOSFET power modules and Trench MOS Barrier Schottky rectifier modules, targeting higher efficiency in automotive, energy, industrial, and telecom power systems. See our latest analysis for Vishay Intertechnology. The recent product launches have arrived alongside a sharp shift in sentiment, with Vishay Intertechnology’s 30 day share price return of 35.19% and 1 year total shareholder return of 30.51% contrasting with...

If you are wondering whether Legend Biotech's current share price still reflects its potential, you are not alone. Many investors are asking the same question after a tough period for the stock. Legend Biotech's share price closed at US$17.15, with returns of a 9.5% decline over 7 days, a 20.3% decline over 30 days, a 20.3% decline year to date, a 54.0% decline over 1 year and a 65.5% decline over 3 years. This performance has reshaped how some investors view both its upside and its...